Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Benzhexol adverse reaction (disorder) |
Causative agent |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
|
benzhexol 2 mg/5 ml sukkerfri oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
|
benzhexolhydrochlorid 5 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
|
Trihexyphenidyl hydrochloride 5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
|
Trihexyphenidyl hydrochloride 2mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
|
trihexyphenidylhydrochlorid kapsel med modificeret udløsning a 5 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
|
Trihexy-2 2mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
|
trihexyphenidylhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely trihexyphenidyl hydrochloride 2 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely trihexyphenidyl hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely trihexyphenidyl hydrochloride 2 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely trihexyphenidyl hydrochloride 2 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely trihexyphenidyl hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely trihexyphenidyl hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Trihexyphenidyl hydrochloride 5mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
|
Benzhexol 2mg/5mL conventional release oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely trihexyphenidyl hydrochloride 2 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely trihexyphenidyl hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Trihexyphenidyl hydrochloride 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Trihexyphenidyl hydrochloride 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trihexyphenidyl hydrochloride (substance) |
Inferred relationship |
Some |
1 |